These data and subsequent analysis suggest that different trajectories of adolescent cannabis use are associated with distinct patterns of neural reward circuit function in early adulthood. Escalating marijuana use presents a higher risk for impaired motivation, including elevated depressive symptoms, anhedonia and poor educational attainment.… Read More »The Influence of Cannabis on the Adolescent Brain
Conclusion: Medical marijuana laws appear to have contributed to increased prevalence of illicit cannabis use and cannabis use disorders. State-specific policy changes may also have played a role. While medical marijuana may help some, cannabis-related health consequences associated with changes in state marijuana laws should… Read More »US Adult Illicit Cannabis Use Disorder & Medical Marijuana Laws:
This review provides an overview of the changing US epidemiology of cannabis use and associated problems. Adults and adolescents increasingly view cannabis as harmless, and some can use cannabis without harm. However, potential problems include harms from prenatal exposure and unintentional childhood exposure; decline in… Read More »US Epidemiology of Cannabis Use and Associated Problems
INTRODUCTION: Cannabis and its synthetic analogues are currently the most widely consumed illicit substances worldwide. Multiple alterations have been linked to its use, including cerebrovascular disease (CVD) or stroke, whose association with the substance has been based mainly on the hypothesis of transient vasoconstriction, which… Read More »Stroke and cannabis use in patients with no cardiovascular risk factors: a systematic review of case reports.
Access to medicinal Cannabis Products (TGA) https://www.tga.gov.au/access-medicinal-cannabis-products Access to medicinal cannabis products: steps to using access … https://www.tga.gov.au/access-medicinal-cannabis-products-steps-using-access-schemes https://www.tga.gov.au/medicinal-cannabis-products-overview-regulation https://www.tga.gov.au/form/medicinal-cannabis-products
The World Health Organisation has announced its findings after a months-long study into cannabidiol, or CBD, declaring the medicinal cannabis component to be well tolerated and an effective treatment for some forms of epilepsy. The WHO also recommended CBD not be a scheduled drug. According to the… Read More »“Medicinal Cannabis (CBD) Has No Abuse Potential”: World Health Organisation
By Carter Sherman Nov 8, 2017 Cannabidiol, a major component of marijuana, is in high demand these days for its purported health benefits. But a study published on Tuesday discovered that people trying to treat themselves with cannabidiol products likely aren’t getting what they’re paying for. The study, led… Read More »CBD products are a rip-off for medical marijuana users, study finds
Highlights Patients with depression frequently used marijuana and nearly half met the AUD criteria. Fewer patients with AUD were using marijuana at baseline compared to patients without AUD. Patients with AUD using marijuana increased over 6 months compared to those without AUD. Patients with AUD… Read More »Adverse impact of marijuana use on clinical outcomes among psychiatry patients with depression and alcohol use disorder
Published 4 December 2017 By Ana Sandoiu Fact checked by Jasmin Collier It’s a well-known fact that many young people use cannabis, and studies have pointed to a link between the drug and psychiatric conditions such as schizophrenia. However, the links between cannabis use and the development of… Read More »Teen marijuana use may lead to bipolar symptoms later on
Schizophrenia Bulletin, sbx158 Published: 28 November 2017 Background Cannabis use in young people is common and associated with psychiatric disorders. However, the prospective link between cannabis use and bipolar disorder symptoms has rarely been investigated. The study hypothesis was that adolescent cannabis use is associated with… Read More »Cannabis Use and Hypomania in Young People: A Prospective Analysis
